KRISTA JONES: Open Payments
NPI 1881160638 · OSAGE BEACH, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,453 in 86 payments from 13 companies in 2025. Trend: 2023 $1,647 · 2024 $1,262 · 2025 $1,453
Food & beverage: $1,369Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $456 |
| Janssen Biotech, Inc. | 8 | $224 |
| Gilead Sciences, Inc. | 14 | $138 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $110 |
| Madrigal Pharmaceuticals | 5 | $104 |
| Phathom Pharmaceuticals, Inc. | 6 | $95 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $88 |
| GENZYME CORPORATION | 2 | $64 |
| Ardelyx, Inc. | 4 | $64 |
| Intercept Pharmaceuticals, Inc. | 3 | $48 |
Products named: TREMFYA, RINVOQ, MAVYRET, XIFAXAN, REZDIFFRA, VOQUEZNA, DUPIXENT, ENTYVIO.
Industry payments across MO — which companies pay providers there.
